Pricing Log in Create free account

QIAGEN N.V. (QGEN) vs Revvity Inc. (RVTY)

QIAGEN N.V. and Revvity Inc. are both Diagnostics & Research companies. Revvity Inc. is the larger, with a market value of $17.3B against $9.5B — 1.8× the size. QIAGEN N.V. trades at the lower P/E: 23.6× against 72.7×. Revvity Inc. grew revenue faster over the last twelve months: 4.05% against 2.96%. QIAGEN N.V. has the higher net margin (19.5% vs 8.16%) and the higher return on invested capital (6.62% vs 2.38%). Both pay a dividend; QIAGEN N.V. yields more (0.76% vs 0.23%). Across the 23 metrics below, QIAGEN N.V. leads on 20 and Revvity Inc. on 3.

Valuation

Metric QGEN RVTY Diagnostics & Research median
P/E 23.64 72.69 35.56
P/S 4.53 5.85 4.37
P/B 2.83 2.36 3.06
Price to free cash flow 21.60 30.14 35.76
EV/EBITDA 15.93 24.77 24.35
EV/Sales 4.94 6.60 5.51
Earnings yield 4.23% 1.38% (1.89%)
Free cash flow yield 4.63% 3.32% (0.15%)

Profitability

Metric QGEN RVTY Diagnostics & Research median
Gross margin 62.20% 54.98% 50.89%
Operating margin 21.21% 12.32% (8.57%)
Net margin 19.49% 8.16% (6.37%)
Free cash flow margin 20.98% 19.58% 0.00%
Return on equity 11.93% 3.21% (2.92%)
Return on assets 6.99% 1.95% (6.71%)
Return on invested capital 6.62% 2.38% 0.00%

Growth

Metric QGEN RVTY Diagnostics & Research median
Revenue growth (TTM) 2.96% 4.05% 7.69%
EPS growth (last fiscal year) 398.07% (5.91%) 25.92%
Revenue growth, 5-year CAGR 2.25% 1.41% 7.40%
Net income growth, 5-year CAGR 3.42% (19.82%) 0.00%

Health

Metric QGEN RVTY Diagnostics & Research median
Debt to equity 0.49 0.44 0.11
Current ratio 2.85 1.80 2.02
Net debt to EBITDA 0.84 3.00 0.70

Dividend

Metric QGEN RVTY Diagnostics & Research median
Dividend yield 0.76% 0.23% 0.66%
Payout ratio 0.18 0.17 0.20

Size

Metric QGEN RVTY Diagnostics & Research median
Market cap 9.51b 17.26b 2.16b

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack